Law360, New York (December 30, 2008, 12:00 AM ET) -- A judge has granted class status to a group of purchasers who sued health care giants Schering-Plough Corp. and Upsher-Smith Laboratories Inc. alleging an anti-competitive pact to keep generic versions of heart drug K-Dur 20 off the shelves.
Judge Joseph Greenaway of the U.S. District Court for the District of New Jersey issued an order Tuesday adopting the recommendation of the special master in the consolidated antitrust action to certify a class of direct purchasers who claim they paid inflated prices for Schering-Plough's brand-name drug....
Judge OKs Class In K-Dur Reverse-Payment Suit
To view the full article, take a free trial now.
